Metraipolis › archive › dc_e058103b56cf

Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review — Europe PMC PMID:41295241

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41295241
DOI
10.3390/jpm15110539
License (as archived)
solo-consultazione
Archived
2026-11-08T18:33:14.511Z
SHA-256 of the archived text
6c0b1c1758ae24a9c6b8c892c6eb56768a1a6fd4aea799da867d5ec36279ba87
Stable URL of this page
https://metraipolis.com/documento/dc_e058103b56cf

How to cite

Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review — Europe PMC PMID:41295241 — Europe PMC (en), https://europepmc.org/article/MED/41295241 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e058103b56cf (Metraipolis archive dc_e058103b56cf, sha256 6c0b1c1758ae24a9c6b8c892c6eb56768a1a6fd4aea799da867d5ec36279ba87)
BibTeX
@misc{dce058103b56cf,
  title = {Exploring the Evidence for Personalized Pharmacotherapy in Type 2 Diabetes-A Systematic Review — Europe PMC PMID:41295241},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41295241},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e058103b56cf; sha256 6c0b1c1758ae24a9c6b8c892c6eb56768a1a6fd4aea799da867d5ec36279ba87},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41295241. Agents can read the archived copy with the MCP tool read_document.